BioTwin creates AI-powered human virtual twins from biological data to enable early detection, personalized and precision medicine.

Corealis is a microbiome sampling platform that gives individuals the power to redefine their health and lifestyle choices

Mashyah is democratizing rehabilitation through an AI-powered HealthTech platform that provides mobile-based functional motion assessment using just a smartphone camera.

Insucare is a startup specialized in manufacturing smart medical devices

Angel City Bio is a drug development company that targets therapies to the intestine and liver with bile acid/drug conjugates. Our lead candidate is a treatment for Crohn’s disease, for which we have compelling proof-of-concept data.

MHCombiotic is developing Combiotic™, a novel antimicrobial for infection control in wounds and respiratory care.

Myogene Therapies are developing gene therapies for the limb girdle muscular dystrophies using next generation vectors.

CellTrio focuses on biobanking and healthcare storage solutions

Z24 Holdings is an early-stage biotech company, having expertise in bioprinting 3D human tissues for drug screening, disease modelling, and tissue transplantation. We target pharma, CROs, academic and healthcare organisations as our customers.

OncoRelix targets the molecular engine behind therapy resistance in aggressive cancers, making the undruggable c-REL transcription factor vulnerable through a novel therapeutic strategy

MelanoTech Labs is a pioneering biotechnology startup specializing in developing full-thickness pigmented skin equivalent (FTSE) models. By fusing biotechnology with AI-driven analytics, our mission is to revolutionize dermatology, enhance clinical accuracy and pave the way for inclusive ethical research.

Astrek Innovations is developing a modular robotic exoskeleton that aids individuals with lower-limb disabilities in rehabilitation and daily mobility, enhancing independence and quality of life.

Zafrens is accelerating drug discovery with ultra-high throughput experiments on patient samples

Whole genome sequencing for every IVF embryo. GenEmbryomics makes preventing genetic disease possible.

Qritive’s AI platform delivers accurate and affordable diagnostics at scale, supporting pathologists in disease identification and grading while enhancing throughput and precision in clinical decision-making.

Pioneera Bio is revolutionizing targeted therapies where >50% of other treatments fail.

GLP-1 Technology is poised to help break the barriers to the $200B Obesity market and aid the world in accessing the essential GLP-1 based drugs.

Kopra Bio makes genetically engineered viruses that teach your immune system to kill cancer.